A. Aytekin Et Al. , "The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases," JOURNAL OF BUON , vol.21, no.1, pp.281-282, 2016
Aytekin, A. Et Al. 2016. The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases. JOURNAL OF BUON , vol.21, no.1 , 281-282.
Aytekin, A., Ciltas, A., Sahinli, H., & Benekli, M., (2016). The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases. JOURNAL OF BUON , vol.21, no.1, 281-282.
Aytekin, Aydin Et Al. "The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases," JOURNAL OF BUON , vol.21, no.1, 281-282, 2016
Aytekin, Aydin Et Al. "The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases." JOURNAL OF BUON , vol.21, no.1, pp.281-282, 2016
Aytekin, A. Et Al. (2016) . "The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases." JOURNAL OF BUON , vol.21, no.1, pp.281-282.
@article{article, author={Aydin Aytekin Et Al. }, title={The role of tyrosine kinase inhibitors in the treatment of renal cell carcinoma with brain metastases}, journal={JOURNAL OF BUON}, year=2016, pages={281-282} }